GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $591,687 | +60.5% | 212,837 | +99.1% | 0.00% | +50.0% |
Q4 2022 | $368,726 | +372.7% | 106,877 | +254.0% | 0.00% | – |
Q3 2022 | $78,000 | -92.2% | 30,191 | -87.6% | 0.00% | -100.0% |
Q1 2022 | $1,004,000 | +52.1% | 243,786 | +248.3% | 0.01% | -10.0% |
Q1 2021 | $660,000 | – | 69,995 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,561,150 | $9,152,000 | 15.60% |
Frazier Life Sciences Management, L.P. | 5,237,348 | $13,460,000 | 1.04% |
Redmile Group, LLC | 6,952,760 | $17,869,000 | 0.69% |
Palo Alto Investors LP | 2,330,504 | $5,989,000 | 0.47% |
ACT CAPITAL MANAGEMENT, LLC | 47,500 | $122,000 | 0.17% |
SkyOak Wealth, LLC | 132,851 | $341,000 | 0.12% |
Artal Group S.A. | 750,000 | $1,928,000 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 77,046 | $198,000 | 0.04% |
CAXTON ASSOCIATES LP | 95,190 | $245,000 | 0.03% |
XTX Topco Ltd | 50,517 | $130,000 | 0.03% |